These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 11549587

  • 1. Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.
    Lu M, Nakamura RM, Dent ED, Zhang JY, Nielsen FC, Christiansen J, Chan EK, Tan EM.
    Am J Pathol; 2001 Sep; 159(3):945-53. PubMed ID: 11549587
    [Abstract] [Full Text] [Related]

  • 2. Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma.
    Zhang J, Chan EK.
    Autoimmun Rev; 2002 May; 1(3):146-53. PubMed ID: 12849008
    [Abstract] [Full Text] [Related]

  • 3. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma.
    Thasler WE, Schlott T, Thelen P, Hellerbrand C, Bataille F, Lichtenauer M, Schlitt HJ, Jauch KW, Weiss TS.
    Histopathology; 2005 Jul; 47(1):57-66. PubMed ID: 15982324
    [Abstract] [Full Text] [Related]

  • 4. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R.
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [Abstract] [Full Text] [Related]

  • 5. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P.
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [Abstract] [Full Text] [Related]

  • 6. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE.
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [Abstract] [Full Text] [Related]

  • 7. Tricellulin expression and its prognostic significance in primary liver carcinomas.
    Somorácz A, Korompay A, Törzsök P, Patonai A, Erdélyi-Belle B, Lotz G, Schaff Z, Kiss A.
    Pathol Oncol Res; 2014 Oct; 20(4):755-64. PubMed ID: 24652413
    [Abstract] [Full Text] [Related]

  • 8. MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis.
    Grudé P, Conti F, Mennecier D, Louvel A, Houssin D, Weill B, Calmus Y.
    Cancer Lett; 2002 Dec 01; 186(1):107-13. PubMed ID: 12183082
    [Abstract] [Full Text] [Related]

  • 9. Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure.
    Xiang X, Qin HG, You XM, Wang YY, Qi LN, Ma L, Xiang BD, Zhong JH, Li LQ.
    Cancer Med; 2017 Oct 01; 6(10):2357-2369. PubMed ID: 28941211
    [Abstract] [Full Text] [Related]

  • 10. Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma.
    Chava S, Lee C, Aydin Y, Chandra PK, Dash A, Chedid M, Thung SN, Moroz K, Wu T, Nayak NC, Dash S.
    Oncotarget; 2017 Jun 20; 8(25):40019-40036. PubMed ID: 28402954
    [Abstract] [Full Text] [Related]

  • 11. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
    Fan W, Yang H, Liu T, Wang J, Li TW, Mavila N, Tang Y, Yang J, Peng H, Tu J, Annamalai A, Noureddin M, Krishnan A, Gores GJ, Martínez-Chantar ML, Mato JM, Lu SC.
    Hepatology; 2017 Apr 20; 65(4):1249-1266. PubMed ID: 27981602
    [Abstract] [Full Text] [Related]

  • 12. Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma.
    Tátrai P, Dudás J, Batmunkh E, Máthé M, Zalatnai A, Schaff Z, Ramadori G, Kovalszky I.
    Lab Invest; 2006 Nov 20; 86(11):1149-60. PubMed ID: 16983329
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. p62 Expression in primary carcinomas of the digestive system.
    Qian HL, Peng XX, Chen SH, Ye HM, Qiu JH.
    World J Gastroenterol; 2005 Mar 28; 11(12):1788-92. PubMed ID: 15793865
    [Abstract] [Full Text] [Related]

  • 15. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma.
    Zhang JY, Chan EK, Peng XX, Tan EM.
    J Exp Med; 1999 Apr 05; 189(7):1101-10. PubMed ID: 10190901
    [Abstract] [Full Text] [Related]

  • 16. Squamous cell carcinoma antigen in human liver carcinogenesis.
    Guido M, Roskams T, Pontisso P, Fassan M, Thung SN, Giacomelli L, Sergio A, Farinati F, Cillo U, Rugge M.
    J Clin Pathol; 2008 Apr 05; 61(4):445-7. PubMed ID: 17893121
    [Abstract] [Full Text] [Related]

  • 17. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.
    He F, Yan Q, Fan L, Liu Y, Cui J, Wang J, Wang L, Wang Y, Wang Z, Guo Y, Huang G.
    Hum Pathol; 2010 Mar 05; 41(3):415-24. PubMed ID: 19954816
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of the anterior gradient protein-2 is a conserved feature during morphogenesis and carcinogenesis of the biliary tree.
    Lepreux S, Bioulac-Sage P, Chevet E.
    Liver Int; 2011 Mar 05; 31(3):322-8. PubMed ID: 21281432
    [Abstract] [Full Text] [Related]

  • 19. Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients.
    Farid RM, Abu-Zeid RM, El-Tawil A.
    Int J Clin Exp Pathol; 2014 Mar 05; 7(5):2707-17. PubMed ID: 24966992
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.